El riesgo y los eventos cardiovasculares en el mundo

REFERENCIAS

1. Murray CJL, Vos T, Lozano R, et al.Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions,1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.Lancet 2012; 380: 2197-223.
2. Walker AR, Walker BF, Segal I. Some puzzling situations in the onset, occurrence and future of coronary heart disease in developed and developing populations, particularly such in sub-Saharan Africa. J R Soc Promot Health 2004; 124:40-6.
3. Marmot M. Coronary heart disease:rise and fall of a modern epidemic. In:
Marmot M, Elliot P, eds. Coronary heart disease epidemiology: from aetiology to public health. Oxford, United Kingdom:Oxford University Press, 1992: 3-19.
4. O’Flaherty M, Buchan I, Capewell S.Contributions of treatment and lifestyle to declining CVD mortality: why have CVD mortality rates declined so much since the 1960s? Heart 2013; 99: 159-62.
5. Stringhini S, Viswanathan B, Gédéon J, Paccaud F, Bovet P. The social transition of risk factors for cardiovascular disease in the African region: evidence from three cross-sectional surveys in the Seychelles. Int J Cardiol 2013; 168: 1201-6.
6. Krishnamurthi RV, Feigin VL, Forouzanfar MH, et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet Glob Health 2013; 1(5): e259- e281.
7. Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf S. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic non communicable diseases in low-, middle-, and high-income countries. Am Heart J 2009; 158(1): 1.e1-7.e1.
8. Corsi DJ, Subramanian SV, Chow CK, et al. Prospective Urban Rural Epidemiology (PURE) study: baseline characteristics of the household sample and comparative analyses with national data in 17 countries. Am Heart J 2013; 166: 636-46
9. Yusuf S, Islam S, Chow CK, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low income countries (the PURE Study): a prospective epidemiological survey. Lancet 2011;  378: 1231-43.
10. Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013; 310: 959-68.
11. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-52.
12. O’Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010; 376: 112-23.
13. Gajalakshmi V, Peto R. Verbal autopsy of 80,000 adult deaths in Tamilnadu, South India. BMC Public Health 2004; 4: 47.
14. Jha P, Gajalakshmi V, Gupta PC, et al. Prospective study of one million deaths in India: rationale, design, and validation results. PLoS Med 2006; 3(2): e18.
15. McGorrian C, Yusuf S, Islam S, et al. Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score. Eur Heart J 2011; 32: 581-9.
16. Tunstall-Pedoe H, Vanuzzo D, Hobbs M, et al. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet 2000; 355:688-700.
17. Wu Z, Yao C, Zhao D, et al. Cardiovascular disease risk factor levels and their relations to CVD rates in China — results of Sino-MONICA project. Eur J Cardiovasc Prev Rehabil 2004; 11: 275-83.